
Pharmaron Beijing Co Ltd
Pharmaron Beijing Co., Ltd. engages in the provision of full-process integrated drug research, development, and production services from drug discovery to drug development. It provides laboratory, CMC, macromolecules and cell & gene therapy, and clinical research services.
What If You Bought PHBBF Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jul 27, 2023 | — | 3-for-2 | 1.5× | 2.25× |
| Jun 14, 2022 | — | 3-for-2 | 1.5× | 1.5× |
Pharmaron Beijing Co Ltd Market Cap Timeline
A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 2 current-security splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.